Terms: = Prostate cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Diagnosis
149 results:
1. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
[TBL] [Abstract] [Full Text] [Related]
2. Deep learning approach for accurate prostate cancer identification and stratification using combined immunostaining of cytokeratin, p63, and racemase.
Salvi M; Manini C; López JI; Fenoglio D; Molinari F
Comput Med Imaging Graph; 2023 Oct; 109():102288. PubMed ID: 37633031
[TBL] [Abstract] [Full Text] [Related]
3. [Clinicopathological Features of Primary Small Cell Neuroendocrine Carcinoma of the Bladder].
Gu YM; Liang XL; Zhang YG; Zhao HY; Jin ML; Li X; Lu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):429-435. PubMed ID: 37407530
[TBL] [Abstract] [Full Text] [Related]
4. Utility of GATA-3 and associated immunohistochemical markers in the differential diagnosis of poorly differentiated urothelial carcinoma.
Naik M; Rao BV; Challa S; Fonseca D; Sudha SM; Giridhar A; Sharma R; Raju KVVN; Rao TS
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147963
[TBL] [Abstract] [Full Text] [Related]
5. Sclerosing Adenosis of the prostate-A Benign Lesion Similar to prostate cancer: A Case Report and Literature Review.
Yao H; Tang G; Cui Y; Wu J
Am J Mens Health; 2022; 16(6):15579883221143182. PubMed ID: 36527372
[TBL] [Abstract] [Full Text] [Related]
6. Use of Prospective Multiplex Immunohistochemistry to Redefine Tissue Pathways of Diagnostic Core Biopsy of prostate.
Thomas T; Wedden S; Afzal N; Mikel J; D'Arrigo C
Appl Immunohistochem Mol Morphol; 2022 Oct; 30(9):585-591. PubMed ID: 36083158
[TBL] [Abstract] [Full Text] [Related]
7. Rapid Histological Assessment of prostate Specimens in the Three-dimensional Space by Hydrophilic Tissue Clearing and Confocal Microscopy.
Peng YC; Lin YC; Hung YL; Fu CC; Chang MD; Lin YY; Chou TY
J Histochem Cytochem; 2022 Aug; 70(8):597-608. PubMed ID: 35912522
[TBL] [Abstract] [Full Text] [Related]
8. p63-positive prostate carcinoma-A very rare presentation.
Lokesha SB; Chowdary BV; Kini JR
Indian J Pathol Microbiol; 2022; 65(2):448-451. PubMed ID: 35435392
[TBL] [Abstract] [Full Text] [Related]
9. [Clinicopathological Features and Expression of P504s,E-cadherin,Erythroblast Transformation-specific Related Gene and Estrogen Receptor in prostate Adenocarcinoma in Tibet].
Luo HH; Huo Z; Xiao Y; Nimazhuoma ; Wang Q; Dazhen ; Cirenquzhen
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):761-766. PubMed ID: 34728038
[TBL] [Abstract] [Full Text] [Related]
10. Intravascular large B cell lymphoma of prostate, a rare entity.
Rallabandi HB; Thirukovela J; Swain M; Meeramira D; Gowrishankar S
Indian J Pathol Microbiol; 2021; 64(3):575-578. PubMed ID: 34341277
[TBL] [Abstract] [Full Text] [Related]
11. Somatic-Type Yolk Sac Tumor Arising as a Predominant Component of Bladder Urothelial Carcinoma.
Collins K; Alkashash AM; Hwang M; Kaimakliotis HZ; Cheng L; Idrees MT
Int J Surg Pathol; 2022 Apr; 30(2):207-213. PubMed ID: 34255554
[TBL] [Abstract] [Full Text] [Related]
12. Performance comparison of anti-p504s (SP116) Rabbit Monoclonal Primary Antibody vs. Monoclonal Rabbit Anti-Human AMACR clone 13H4 when duplexed with VENTANA Basal Cell Cocktail (34βE12+p63) as a diagnostic aid for prostatic adenocarcinoma using immunohistochemistry.
Lindner V; Waydelich A; Chen CC; Jones C; Stratton SP
Virchows Arch; 2021 Aug; 479(2):337-343. PubMed ID: 33811532
[TBL] [Abstract] [Full Text] [Related]
13. Improving prostate cancer classification in H&E tissue micro arrays using Ki67 and p63 histopathology.
Shao Y; Nir G; Fazli L; Goldenberg L; Gleave M; Black P; Wang J; Salcudean S
Comput Biol Med; 2020 Dec; 127():104053. PubMed ID: 33126125
[TBL] [Abstract] [Full Text] [Related]
14. diagnosis of prostate cancer in one day: The benefits of cytology in tumour detection.
Compérat E; Renard-Penna R; Ondet V; Cancel-Tassin G; Cussenot O
Cytopathology; 2021 Mar; 32(2):211-216. PubMed ID: 33107101
[TBL] [Abstract] [Full Text] [Related]
15. Serum total prostate-specific antigen (tPSA): correlation with diagnosis and grading of prostate cancer in core needle biopsy.
Čamdžić N; Kuskunović-Vlahovljak S; Dorić M; Radović S; Lazović Salčin E; Babić M
Med Glas (Zenica); 2021 Feb; 18(1):122-127. PubMed ID: 32815673
[TBL] [Abstract] [Full Text] [Related]
16. Malignant solitary fibrous tumour of the prostate: four cases emphasising significant histological and immunophenotypical overlap with sarcomatoid carcinoma.
Bakhshwin A; Berry RS; Cox RM; Li R; Reynolds JP; Rubin BP; McKenney JK
Pathology; 2020 Oct; 52(6):643-648. PubMed ID: 32758370
[TBL] [Abstract] [Full Text] [Related]
17. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
Chan E; Garg K; Stohr BA
Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
[TBL] [Abstract] [Full Text] [Related]
18. Plasmacytoid acinar adenocarcinoma of the prostate: a newly described variant of prostate cancer.
Al-Hussain T; Haffner MC; Altaweel WM; Epstein JI
Hum Pathol; 2019 Dec; 94():86-91. PubMed ID: 31698007
[TBL] [Abstract] [Full Text] [Related]
19. Primary Extracranial Meningioma of Mastoid in a Patient With History of Skin Squamous Cell Carcinoma, Lung Adenocarcinoma and Prostatic Carcinoma.
Hu M; Tang Y; Long G; Zhang D; Kresak JL; Lai J
Anticancer Res; 2019 Jun; 39(6):3197-3201. PubMed ID: 31177167
[TBL] [Abstract] [Full Text] [Related]
20. Signature maps for automatic identification of prostate cancer from colorimetric analysis of H&E- and IHC-stained histopathological specimens.
Leng E; Henriksen JC; Rizzardi AE; Jin J; Nam JW; Brassuer BM; Johnson AD; Reder NP; Koopmeiners JS; Schmechel SC; Metzger GJ
Sci Rep; 2019 May; 9(1):6992. PubMed ID: 31061447
[TBL] [Abstract] [Full Text] [Related]
[Next]
